The fast evolution of GLP-1 medications raises questions about safety and side effects

GLP-1 medications are evolving quickly.There’s no longer just Ozempic and Mounjaro. There are more than five types of the drugs across at least one dozen different brands.Plus, a new pill version is hitting the market, which is easier to administer than the shots.As the drugs get cheaper and easier to take, people are asking questions about potential side effects, long-term safety and regulation.Some experts are also asking how appetite-suppressing medications are changing our relationship with food — and what that means for eating disorders and nutritionWe will unpack the updates, benefits and risks from a medical, nutrition and psychological perspective.Guests:Ken Alltucker, consumer health reporter, USA TodayDr. Aradhna Saraswat, physician/assistant professor, Center for Women’s Health, Wexner Medical CenterZoe Ross-Nash, PsyD, licensed clinical psychologist/certified eating disorder specialist/founder, Equilibrium Health AdvantageIf you have a disability and would like a transcript or other accommodation you can request an alternative format.(photo: David J. Phillip / AP)